US 7825126
Purine derivatives as A3 and A1 adenosine receptor agonists
granted A61PA61P11/06A61P13/12
Quick answer
US patent 7825126 (Purine derivatives as A3 and A1 adenosine receptor agonists) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 57
- CPC classes
- A61P, A61P11/06, A61P13/12, A61P15/08, A61P15/16